Truist Financial’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$375K Buy
11,950
+2,332
+24% +$98.4K ﹤0.01% 2402
2026
Q1
$532K Buy
9,618
+3,041
+46% +$145K ﹤0.01% 2057
2025
Q4
$246K Buy
+6,577
New +$267K ﹤0.01% 2468
2024
Q3
Sell
-18,371
Closed -$308K 2668
2024
Q2
$308K Buy
+18,371
New +$295K ﹤0.01% 2281
2021
Q3
Sell
-11,940
Closed -$345K 2787
2021
Q2
$345K Buy
+11,940
New +$323K ﹤0.01% 2288

Other funds holding PAHC

Truist Financial's PAHC Position: Q2 2026 in Review

Truist Financial increased its Phibro Animal Health (PAHC) stake by 24% in Q2 2026, buying an estimated $98.4K and bringing the position to 11,950 shares worth $375K. The position accounts for ﹤0.01% of the portfolio, ranked #2402.

Truist Financial first reported a position in PAHC in Q2 2021 and has held it in 5 quarters since. The position peaked at $532K in Q1 2026. 37 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Truist Financial held 11,950 shares of Phibro Animal Health worth $375K as of Q2 2026.
  • Truist Financial bought 2,332 Phibro Animal Health shares in Q2 2026, an estimated $98.4K.
  • Phibro Animal Health made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #2402 holding.
  • Truist Financial first reported a position in Phibro Animal Health in Q2 2021 and has held it in 5 quarters since.
  • Truist Financial's Phibro Animal Health position peaked at $532K in Q1 2026.
  • 37 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.